Executive Clinical Snapshot
Prof. Zhihui Li, MD, PhD, is Director and Chief Surgeon of the Department of Thyroid Surgery at West China Hospital, Sichuan University. As one of China's most acclaimed master endocrine surgical oncologists, Prof. Li has pioneered transformative techniques that resolve the core dilemmas of thyroid surgery: Radical Eradication of Advanced Invasive Thyroid Carcinomas balanced with Total Anatomical and Functional Preservation of Parathyroid Glands and Laryngeal Nerves. Furthermore, Prof. Li is an internationally renowned leader in scarless minimally invasive surgery, including transoral endoscopic thyroidectomy vestibular approach (TOETVA) and robotic-assisted endocrine resections.
Academic Leadership & National Standing
- Director & Chief Surgeon, Department of Thyroid Surgery, West China Hospital, Sichuan University.
- Vice Chairman, Thyroid Surgeon Committee of the Chinese Medical Doctor Association (CMDA).
- Standing Committee Member, Thyroid Cancer Committee of the Chinese Society of Clinical Oncology (CSCO).
- Vice Chairman, Thyroid Cancer Professional Committee of the Chinese Anti-Cancer Association (CACA).
- Chairman, Sichuan Provincial Thyroid Surgery Quality Control Center.
- Principal Investigator for national multicenter trials evaluating carbon nanoparticle tracer applications, real-time continuous intraoperative neuromonitoring (C-IONM), and multikinase inhibitor downstaging in locally advanced thyroid malignancies.
Surgical Breakthroughs: The Triad of Precision Thyroid Oncology
Traditional thyroid cancer surgery carries significant risks of permanent hypocalcemia (from accidental devascularization or excision of the parathyroid glands) and vocal cord paralysis (from injury to the recurrent laryngeal nerve). Prof. Li developed a world-class surgical paradigm built on three technological pillars:
Key Innovations Spearheaded by Prof. Zhihui Li:
- Carbon Nanoparticle Negative Imaging for Parathyroid Protection: Injected into the thyroid parenchyma, ultra-fine 150 nm carbon nanoparticles selectively enter the lymphatic vessels, staining the thyroid gland and draining lymph nodes jet-black while sparing the parathyroid glands, which remain their natural golden-brown hue. This negative contrast enables pristine in-situ parathyroid preservation and thorough central lymph node clearance.
- Continuous Intraoperative Neuromonitoring (C-IONM): Utilizes automatic periodic vagal nerve stimulation to continuously monitor electrophysiological conduction along the recurrent laryngeal nerve (RLN) and external branch of the superior laryngeal nerve (EBSLN), eliminating thermal and traction injuries and preserving vocal cord mobility and pitch modulation.
- Scarless Transoral Endoscopic Thyroidectomy (TOETVA): Performed entirely through three small incisions inside the oral vestibule behind the lower lip, leaving zero visible surgical scars on the neck or body while providing exceptional bottom-up endoscopic magnification of the central compartment lymph nodes.
- Tracheal & Laryngeal Shaving for Locally Advanced Disease: Advanced organ-preserving shaving and window resection techniques for tumors invading the tracheal cartilage or recurrent laryngeal nerve, restoring clear margins without necessitating permanent tracheostomies.
Comprehensive Endocrine Surgical Spectrum
- Advanced & Invasive Thyroid Carcinomas: Papillary thyroid carcinoma (PTC) with extensive extrathyroidal extension (ETE) into the trachea, esophagus, recurrent laryngeal nerve, or internal jugular vein.
- Extensive Neck Lymph Node Dissections: Compartment-oriented en bloc central (Level VI/VII) and modified radical lateral neck dissections (Levels II, III, IV, V) for bulky or recurrent nodal metastases.
- Medullary & Anaplastic Thyroid Cancers: Multi-modality surgical clearance combined with targeted RET inhibitors or neoadjuvant BRAF/MEK targeted downstaging.
- Minimally Invasive & Scarless Endoscopic Thyroidectomy: Transoral vestibular (TOETVA), transaxillary, and bilateral axillo-breast approach (BABA) for indeterminate nodules and early-stage carcinomas.
- Secondary & Tertiary Hyperparathyroidism: Subtotal parathyroidectomy and total parathyroidectomy with forearm autotransplantation for refractory renal osteodystrophy.
Benchmark Clinical Scenarios
Scenario A: Recurrent Advanced PTC Invading Trachea and Carotid Sheath
A 51-year-old male suffered locally recurrent papillary thyroid carcinoma following two prior open surgeries elsewhere. Imaging revealed a 4 cm infiltrating mass wrapping 180 degrees around the right common carotid artery and invading two cartilaginous rings of the anterolateral trachea. Prof. Li executed an ultra-radical re-operation: utilizing carbon nanoparticle delineation, two inferior parathyroid glands were identified and autotransplanted into the sternocleidomastoid muscle. Under continuous neuromonitoring, the tumor was microscopically peeled off the carotid sheath, and a tangential tracheal window resection with primary reconstruction was accomplished. Complete R0 resection was attained with intact vocal cord movement and normal postoperative serum calcium levels.
Scenario B: Scarless TOETVA for Central Papillary Microcarcinoma in a Young Vocalist
A 27-year-old professional singer presented with a 9 mm papillary thyroid carcinoma in the right thyroid lobe and suspicious central lymph nodes. Desperately requiring both complete cure and avoidance of neck scaring or voice changes, Prof. Li performed a transoral endoscopic right hemithyroidectomy with ipsilateral central neck dissection (TOETVA). Under continuous C-IONM, both branches of the laryngeal nerves were meticulously preserved. All 8 harvested lymph nodes were negative, voice pitch analysis demonstrated zero frequency loss, and the oral mucosal incisions healed invisibly within two weeks.
Scientific Impact & Global Masterclasses
Prof. Zhihui Li has published over 170 papers in top surgical and endocrine oncology journals including Thyroid, Head & Neck, Surgical Endoscopy, and World Journal of Surgery. He has trained hundreds of endocrine surgeons across China and internationally in parathyroid preservation and transoral endoscopic procedures, authoring benchmark Chinese guidelines on nanocarbon tracer applications and endoscopic thyroid surgery.
International Patient Access via CMCS
Cross-border patients diagnosed with thyroid nodules, suspected malignancies, or recurrent cervical lymphadenopathy can coordinate directly with Prof. Zhihui Li's surgical team at West China Hospital via China Medical Concierge – Shanghai (CMCS):
- High-Resolution Ultrasound & Molecular Panel Review: Secondary digital review of thyroid color Doppler ultrasonography, neck contrast CT/MRI, and molecular testing (BRAF V600E, TERT, RET/PTC) prior to international travel.
- Virtual Pre-Travel Surgical Consultation: Structured video conference with Prof. Li to determine suitability for scarless endoscopic thyroidectomy (TOETVA) versus radical open reconstruction.
- Expedited Operating Theater Scheduling: Priority inpatient admission to West China Hospital's specialized endocrine surgical suites.
- Bilingual Case Coordination: Dedicated medical accompaniment, daily bedside translation, wound care management, and postoperative vocal cord and parathyroid surveillance.
- Post-Discharge Cross-Border Follow-up: Digital tracking of serum thyroglobulin (Tg), parathyroid hormone (PTH), and calcium levels in coordination with local endocrinologists.
Connect with CMCS Medical Concierge
For confidential endocrine oncology inquiries, ultrasound reviews, or to schedule a surgical evaluation with Prof. Zhihui Li:
Email: contract@medicalsh.com
WhatsApp: Connect on WhatsApp
Official Website: www.medicalsh.com
0 commentaire